Sponsors are being reminded that they must meet current regulatory expectations regarding FDA standards, including those set by ICH.
1 report, 1 independent
Updated Jun 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Sponsors are being reminded that they must meet current regulatory expectations regarding FDA standards, including those set by ICH.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- FDA ensures products meet rigorous standards involving Unilab.Sub-event
General reminder that sponsors must adhere to current FDA and ICH regulatory expectations.1 source
Keep exploring
The entities involved
Related events
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- Industry trends are influenced by regulatory body requests, according to a recent report involving RTI International.
- Future sales of a product are contingent upon obtaining the necessary FDA registration and labeling, while the state simultaneously announces actions to remove regulatory barriers.
- A product was launched in the U.S. market following FDA involvement.
- FDA approval enables commercial opportunity involving CBRE Group.